Premium regenerative support for chronic and complex wounds
Amnio-MAXX®, available through Semper Fi Medical Supplies in partnership with Royal Biologics, is a next-generation amniotic membrane allograft designed to promote faster, more complete wound healing in a wide range of clinical settings. Rich in native growth factors, cytokines, and extracellular matrix proteins, Amnio-Maxx® supports a regenerative environment that reduces inflammation, limits scarring, and accelerates re-epithelialization.
Minimally manipulated and naturally preserved, Amnio-Maxx® is processed for safety and consistency while retaining the essential biologic components required for effective healing.
Sizes
- Amnio-MAXX® 2×2 cm
- Amnio-MAXX® 2×3 cm
- Amnio-MAXX® 2×4 cm
- Amnio-MAXX® 4×4 cm
- Amnio-MAXX® 4×6 cm
- Amnio-MAXX® 4×8 cm
Key product highlights
Biologically active composition
Retains native growth factors, collagen, and cytokines critical for tissue regeneration.
Anti-inflammatory & antimicrobial properties
Naturally reduces inflammatory response and provides an added layer of infection resistance.
Scaffold for cellular regeneration
Provides a biologic matrix that encourages cell migration, vascularization, and dermal reconstruction.
Sterile & easy to handle
Comes in multiple size options, with shelf-stable, single-use packaging for procedural flexibility.
No orientation required
Simplifies clinical application with dual-sided usability.
Why choose Amnio-Maxx® from Semper Fi Medical Supplies?
-
End-to-end support
From onboarding to clinical integration, we offer training, product education, and documentation guidance.e -
Aligned with reimbursement
Semper Fi Medical Supplies provides reimbursement coding assistance and payer navigation to streamline adoption. -
Part of a complete biologics portfolio
Amnio-Maxx® works seamlessly alongside Xcell Amnio Matrix™, Xcellerate®, Membrane Wrap™, and Derm-Maxx™ — allowing providers to customize protocols based on wound severity and healing phase. -
FDA registered and compliant
Processed under strict safety standards as a 361 HCT/P tissue allograft.
Clinical Applications
- Diabetic Foot Ulcers (DFUs)
- Venous Leg Ulcers (VLUs)
- Pressure Injuries
- Surgical Wounds and Post-Operative Dehiscence
- Soft Tissue Defects
- Graft Donor and Recipient Sites
- Traumatic Wounds and Lacerations
Ordering Information
| Product Description | Size | Product Code |
|---|---|---|
| Q4239 Amnio-Maxx® Dual Layer Amnion Allograft | 2cm x 2cm | AMN-22 |
| Q4239 Amnio-Maxx® Dual Layer Amnion Allograft | 2cm x 3cm | AMN-23 |
| Q4239 Amnio-Maxx® Dual Layer Amnion Allograft | 2cm x 4cm | AMN-24 |
| Q4239 Amnio-Maxx® Lite, Single Amnion Allograft | 4cm x 4cm | AML-44 |
| Q4239 Amnio-Maxx® Dual Layer Amnion Allograft | 4cm x 6cm | AMN-46 |
| Q4239 Amnio-Maxx® Dual Layer Amnion Allograft | 4cm x 8cm | AMN-48 |